Anuh Pharma — 360° view

Anuh Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹185 crore and net profit of ₹11 crore for the September 2026 quarter.

Anuh Pharma (NSE: ANUHPHR) closed at ₹79.28 on 20 Nov 2026, down 1.2% over the past year. Its market capitalisation is ₹795 crore and it trades at 16.6 times earnings.

Share price
₹79.28 (20 Nov 2026)
Market cap
₹795 Cr (20 Nov 2026)
P/E
16.63 (20 Nov 2026)
Revenue
₹185 Cr (September 2026 quarter)
Net profit
₹11 Cr (September 2026 quarter)
ROCE
14.9% (FY26)
ROE
11.3% (FY26)
Book value
₹35.9 (FY26)
Dividend yield
1.89% (last 12 months to 20 Nov 2026)
52-week high / low
₹99.50 / ₹67.00 (20 Nov 2026)
1-year return
-1.2% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ANUHPHR

Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.